1. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Issue 2 (February 2022) Authors: Siefker-Radtke, Arlene O; Necchi, Andrea; Park, Se Hoon; García-Donas, Jesús; Huddart, Robert A; Burgess, Earle F; Fleming, Mark T; Rezazadeh Kalebasty, Arash; Mellado, Begoña; Varlamov, Sergei; Joshi, Monika; Duran, Ignacio; Tagawa, Scott T; Zakharia, Yousef; Akapame, Sydney; Santiago-Walker, Ad... Journal: Lancet oncology Issue: Volume 23:Issue 2(2022) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeted treatment approaches in refractory germ cell tumors. (November 2019) Authors: Galvez-Carvajal, Laura; Sanchez-Muñoz, Alfonso; Ribelles, Nuria; Saez, Maribel; Baena, Javier; Ruiz, Sofia; Ithurbisquy, Catherine; Alba, Emilio Journal: Critical reviews in oncology/hematology Issue: Volume 143(2019) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗